Brooktree Capital Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Brooktree Capital Management's JNJ Position: Q2 2026 in Review
Brooktree Capital Management increased its Johnson & Johnson (JNJ) stake by 0.22% in Q2 2026, buying an estimated $7.69K and bringing the position to 14,936 shares worth $3.79M. The position accounts for 2.48% of the portfolio, ranked #11.
Brooktree Capital Management first reported a position in JNJ in Q4 2019 and has held it in 27 quarters since. The position peaked at $6.18M in Q4 2025. 4,685 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Brooktree Capital Management held 14,936 shares of Johnson & Johnson worth $3.79M as of Q2 2026.
- Brooktree Capital Management bought 33 Johnson & Johnson shares in Q2 2026, an estimated $7.69K.
- Johnson & Johnson made up 2.48% of Brooktree Capital Management's portfolio in Q2 2026, its #11 holding.
- Brooktree Capital Management first reported a position in Johnson & Johnson in Q4 2019 and has held it in 27 quarters since.
- Brooktree Capital Management's Johnson & Johnson position peaked at $6.18M in Q4 2025.
- 4,685 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Brooktree Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.